Contract Development Services

Apr 20, 2018
By Pharmaceutical Technology Editors
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
Apr 06, 2018
By Pharmaceutical Technology Editors
Anthony Qu, PhD, vice president of Scientific Affairs at Halo Pharma, will give a presentation on fixed-dose combination products, drug products containing multiple active ingredients, as an effective approach for simplified dosing at CPhI North America on Wednesday, April 25, 2018 in Philadelphia, PA.
Apr 05, 2018
By Pharmaceutical Technology Editors
The contract development and manufacturing organization announced the addition of a new building complex that will house its headquarters in Bothell, WA.
Mar 19, 2018
By Pharmaceutical Technology Editors
Hovione plans to continue to expand its sites in Portugal and Ireland for chemical synthesis, spray drying, and laboratory analysis.
Feb 13, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
Feb 09, 2018
By Pharmaceutical Technology Editors
The companies will partner to further immuno-oncology research using humanized mice.
Feb 02, 2018
Pharmaceutical Technology
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
Feb 01, 2018
Pharmaceutical Technology
Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology.
Feb 01, 2018
Pharmaceutical Technology
Research suggests that working with a single contract partner can reduce development time and improve economics.
Feb 01, 2018
Pharmaceutical Technology
CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them.
native1_300x100
lorem ipsum